End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 AUD | +17.65% | -3.23% | -36.84% |
May. 07 | Argent BioPharma Reports CFO Appointment | MT |
May. 07 | Argent BioPharma shares begin trading on OTCQB Venture Market | AN |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cannabinoids
74.0
%
| 4 | 85.1 % | 3 | 74.0 % | -37.74% |
Non-pharma
25.8
%
| 0 | 4.8 % | 1 | 25.8 % | +282.89% |
Consulting Services
0.2
%
| 0 | 10.1 % | 0 | 0.2 % | -98.54% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Slovenia
84.0
%
| 3 | 68.0 % | 3 | 84.0 % | -11.58% |
Australia and Others
15.8
%
| 1 | 22.3 % | 1 | 15.8 % | -49.46% |
Israel
0.2
%
| 0 | 9.6 % | 0 | 0.2 % | -98.45% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 05-10-20 |
Yifat Steuer
COO | Chief Operating Officer | 53 | 22-10-03 |
Nadya Lisovoder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rowan Harland
SEC | Corporate Secretary | - | 23-02-28 |
Robert Clements
PRN | Corporate Officer/Principal | - | 22-07-18 |
Corporate Officer/Principal | - | 20-11-30 | |
Amir Polak
PRN | Corporate Officer/Principal | - | 20-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Roby Zomer
FOU | Founder | 44 | 05-10-20 |
Director/Board Member | - | 23-05-31 | |
Daniel Robinson
BRD | Director/Board Member | - | Nov. 30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,491,631 | 3,446,355 ( 9.444 %) | 0 | 9.444 % |
Company contact information
MGC Pharmaceuticals Ltd.
295 Rokeby Road Suite 1
6008, Subiaco
+61 8 6555 2950
http://www.mgcpharma.com.auSector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.84% | 7.68M | |
+28.10% | 5.68B | |
-33.42% | 3.61B | |
-3.33% | 3.11B | |
-26.20% | 2.65B | |
-9.99% | 2.33B | |
+40.09% | 1.89B | |
+40.90% | 1.49B | |
-12.94% | 1.46B | |
+46.67% | 1.37B |
- Stock Market
- Equities
- RGT Stock
- Company Argent BioPharma Limited